Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eder

Showing results (31-40 of 283) with videos related to

Pageof 29
Sort By:
Oligonucleotides|March 6, 2004
Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation modelMichaela Scherr, Karin Battmer, Iris Dallmann, et al.
Pharmaceuticals (Basel, Switzerland)|January 26, 2019
[<sup>177</sup>Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative <i>In Vitro</i> AutoradiographyRoswitha Tönnesmann, Philipp T Meyer, Matthias Eder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2016
New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and TherapyUwe Haberkorn, Matthias Eder, Klaus Kopka, et al.
Anesthesiology|November 26, 2009
Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal hornRainer Haseneder, Stephan Kratzer, Eberhard Kochs, et al.
Anesthesiology|February 2, 2012
Xenon attenuates hippocampal long-term potentiation by diminishing synaptic and extrasynaptic N-methyl-D-aspartate receptor currentsStephan Kratzer, Corinna Mattusch, Eberhard Kochs, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Oligonucleotides|April 28, 2007
Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture modelAnuhar Chaturvedi, Karin Battmer, Daniel Schaefer, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Translational Psychiatry|October 6, 2024
Cacna1c deficiency in forebrain glutamatergic neurons alters behavior and hippocampal plasticity in female miceSrivaishnavi Loganathan, Danusa Menegaz, Jan Philipp Delling, et al.
Nature Communications|December 12, 2025
Engineering the auxin-inducible degron system for tunable in vivo control of organismal physiologyJeremy Vicencio, Daisuke Chihara, Matthias Eder, et al.
Pageof 29

Showing results (31-40 of 283) with videos related to

Sort By:
Pageof 29
Oligonucleotides|March 6, 2004
Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation modelMichaela Scherr, Karin Battmer, Iris Dallmann, et al.
Pharmaceuticals (Basel, Switzerland)|January 26, 2019
[<sup>177</sup>Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative <i>In Vitro</i> AutoradiographyRoswitha Tönnesmann, Philipp T Meyer, Matthias Eder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2016
New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and TherapyUwe Haberkorn, Matthias Eder, Klaus Kopka, et al.
Anesthesiology|November 26, 2009
Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal hornRainer Haseneder, Stephan Kratzer, Eberhard Kochs, et al.
Anesthesiology|February 2, 2012
Xenon attenuates hippocampal long-term potentiation by diminishing synaptic and extrasynaptic N-methyl-D-aspartate receptor currentsStephan Kratzer, Corinna Mattusch, Eberhard Kochs, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Oligonucleotides|April 28, 2007
Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture modelAnuhar Chaturvedi, Karin Battmer, Daniel Schaefer, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Translational Psychiatry|October 6, 2024
Cacna1c deficiency in forebrain glutamatergic neurons alters behavior and hippocampal plasticity in female miceSrivaishnavi Loganathan, Danusa Menegaz, Jan Philipp Delling, et al.
Nature Communications|December 12, 2025
Engineering the auxin-inducible degron system for tunable in vivo control of organismal physiologyJeremy Vicencio, Daisuke Chihara, Matthias Eder, et al.
Pageof 29